Focal Therapy for Prostate Cancer
Understanding targeted treatment options for carefully selected men with localised prostate cancer
Overview
Focal therapy is an emerging treatment approach for carefully selected men with localised prostate cancer. Instead of treating the entire prostate gland, focal therapy aims to target the area where clinically significant cancer has been identified, while preserving more surrounding prostate tissue.
This approach may help reduce some treatment-related side effects in selected patients. However, focal therapy is not suitable for all prostate cancers, and careful assessment, patient selection, and long-term follow-up remain essential.
Key point
Focal therapy is not suitable for every prostate cancer. It is usually considered only when imaging and biopsy findings suggest that clinically significant cancer is limited to a selected area of the prostate.
What Is Focal Therapy?
Focal therapy is a targeted treatment strategy used in selected cases of prostate cancer where the cancer appears confined to a limited area of the prostate.
Rather than removing or treating the whole prostate gland, focal therapy focuses on the identified cancerous area while aiming to preserve surrounding healthy tissue and nearby structures involved in urinary and sexual function.
It is sometimes considered a “middle-ground” option between active surveillance and whole-gland treatment, such as robotic prostatectomy or radiotherapy.
However, focal therapy is not appropriate for every patient. Careful assessment is needed to determine whether the cancer pattern, grade, location, and overall risk profile are suitable for this approach.
Where Focal Therapy Fits
Prostate cancer treatment may range from close monitoring to targeted treatment or whole-gland treatment, depending on the cancer pattern and overall risk assessment.
Active Surveillance
Close monitoring of low-risk prostate cancer without immediate treatment.
Usually involves PSA testing, MRI, clinical review, and repeat biopsy when needed.
Focal Therapy
Targeted treatment of selected cancer areas while preserving more surrounding prostate tissue.
May be considered only when imaging and biopsy findings suggest suitable localised disease.
Whole-Gland Treatment
Treatment of the entire prostate gland, such as robotic prostatectomy or radiotherapy.
May be more appropriate when cancer is more extensive, more aggressive, or not suitable for focal treatment.
How Is Prostate Cancer Assessed Before Focal Therapy?
Focal therapy depends on accurately identifying where the cancer is located within the prostate.
Assessment may include:
- PSA testing
- Multiparametric MRI of the prostate
- Targeted prostate biopsy
- Systematic prostate biopsy
- Review of cancer grade, stage, and risk category
The aim is to determine whether the cancer appears limited to one area, and whether there is any concern for more extensive or aggressive disease.
Because prostate cancer can sometimes be present in more than one part of the gland, careful evaluation is essential before considering focal therapy.
This section is important because focal therapy is not just about the treatment device — it is about selection and mapping.
Why assessment matters
Focal therapy depends on accurate cancer mapping. MRI and biopsy findings help determine whether the cancer appears limited enough for a targeted approach.
Types of Focal Therapy
Several focal therapy technologies have been developed for carefully selected cases of localised prostate cancer. The aim is to treat the identified cancer area while preserving more surrounding prostate tissue where appropriate.
High-Intensity Focused Ultrasound (HIFU)
HIFU uses focused ultrasound energy to generate heat and destroy targeted prostate tissue.
Cryotherapy
Cryotherapy uses controlled freezing to treat selected areas of prostate tissue.
Irreversible Electroporation (IRE)
IRE uses electrical pulses to disrupt selected cancer cells while aiming to preserve nearby structures.
Other Emerging Techniques
Other focal treatment methods continue to evolve as research, imaging and treatment technology develop.
The most appropriate technique depends on cancer characteristics, imaging findings, biopsy results, anatomy, treatment goals, and available expertise.
Potential Advantages of Focal Therapy
In carefully selected patients, focal therapy may offer potential advantages such as:
- Reduced impact on urinary control
- Lower risk of erectile dysfunction compared with some whole-gland treatments
- Shorter recovery time
- Preservation of more normal prostate tissue
However, outcomes vary between individuals. Focal therapy is still cancer treatment, and no treatment is completely free from risks, side effects, or the need for follow-up.
Who May Be Considered for Focal Therapy?
Focal therapy may be discussed in selected men with localised prostate cancer when assessment suggests that targeted treatment may be appropriate.
This may include situations where:
- The cancer appears visibly limited to a defined area of the prostate
- MRI and biopsy findings are consistent with localised disease
- The cancer risk profile is suitable for a targeted approach
- The patient understands the need for structured follow-up
- Whole-gland treatment may not be the preferred first option after careful discussion
Focal therapy is not decided by one test alone. It depends on the overall cancer pattern, biopsy results, imaging findings, health factors, and treatment goals.
Limitations and Considerations
Focal therapy also has important limitations. Not all prostate cancers are suitable for focal treatment, particularly when:
- Cancer is found in multiple areas of the prostate
- The cancer appears more aggressive
- MRI or biopsy findings suggest more widespread disease
- The cancer is close to important structures
- There is uncertainty about the true extent of disease
In some situations, standard treatments such as robotic prostatectomy or radiotherapy may remain more appropriate.
It is also important to understand that long-term cancer control data for some focal therapy techniques continues to evolve. Men considering focal therapy should be prepared for structured follow-up after treatment.
Important considerations
Focal therapy may reduce treatment impact in selected patients, but it still requires long-term follow-up. Some men may need further treatment if cancer persists, recurs, or is later found elsewhere in the prostate.
The Importance of Follow-Up After Focal Therapy
Even after focal therapy, ongoing surveillance remains important.
Follow-up may include:
- PSA monitoring
- Repeat prostate MRI scans
- Repeat prostate biopsy in selected cases
- Clinical review and symptom assessment
This helps monitor treatment response and detect any signs of persistent or recurrent cancer.
Focal therapy should not be viewed as a “one-off” treatment without further monitoring. Ongoing surveillance is part of the treatment pathway.
Is Focal Therapy Right for Everyone?
No. Focal therapy is only suitable for selected patients.
Treatment decisions for prostate cancer should be individualised based on:
- Cancer grade and stage
- MRI and biopsy findings
- PSA level
- Age and general health
- Urinary and sexual function priorities
- Long-term cancer control goals
- Personal treatment preferences
A detailed discussion with a urologist experienced in prostate cancer management is important before deciding whether focal therapy, active surveillance, robotic prostatectomy, radiotherapy, or another treatment pathway is most appropriate.
Discussing Treatment Options for Localised Prostate Cancer
Prostate cancer treatment should be individualised. The most appropriate approach depends on cancer characteristics, imaging and biopsy findings, overall health, urinary and sexual function priorities, and long-term treatment goals.
A consultation can help clarify whether focal therapy, active surveillance, robotic prostatectomy, radiotherapy, or another treatment pathway may be appropriate.
Appointments and assessments are arranged through Prince Court Medical Centre.